Place of Origin:
Henan,China
Brand Name:
CXBT
Certification:
ISO9001,ISO22000,ISO14001,ISO45001,GAP,GMP,cGMP
Model Number:
Veterinary tablets
FUBEIKANG
1. Biological immune peptides
Activate macrophages and lymphocytes, enhance the body's immune system, regulate immune balance, reduce excessive inflammation and immune storms, promote immune cell repair, improve antiviral and anti infective abilities, and assist in repairing mucosal barriers (respiratory tract, intestinal tract)
2. Curcumin
Strong anti-inflammatory and antioxidant properties, reduce inflammation, enhance NK cell activity, strengthen self antiviral ability, protect liver cells, alleviate liver damage caused by dru-gs or viruses, inhibit inflammatory factors, and assist in alleviating immune hyperactivity
3. Melittin
Directly destroy the viral envelope and have inhibitory effects on enveloped RNA viruses (such as coronaviruses)
Strong anti-inflammatory, antibacterial, and antiviral properties
Regulating immunity and suppressing excessive inflammatory response
Promote local circulation and assist in repairing tissue damage
4. Glutathione
Strong antioxidant properties eliminate free radicals, reduce cellular oxidative damage, and protect the liver, nerves, and immune cells.
Liver protection promotes liver detoxification and reduces the damage of dru-gs, toxins, and viruses to liver cells.
![]()
Successful treatment cases
Collection of successful treatment cases of feline infectious peritonitis. With the application of antiviral dru-g Fubeikang, feline infectious peritonitis (FIP) has transformed from a "terminal disease" to a curable disease. The following is a collection of multiple successful treatment cases reported in recent years, covering different types and difficulties of FIP.
1, Atypical FIP: Granulomatous lesion of transverse colon Case overview: Long term survival at 44 months Cat: 7-year-old sterilized male domestic Shorthair Cat, weighing 3.5-4.0kg
Clinical manifestations: Decreased appetite, intermittent vomiting (once a week, small but frequent)
Core medication of treatment plan: 1 capsule/5kg of Fubeikang, once a day, for a course of 12 weeks
Adjuvant therapy: symptomatic supportive therapy (discontinued on the 7th day)
Key results: After 3 days of treatment, gastrointestinal symptoms improved and FCoV antibodies turned negative. PCR testing was negative and the patient remained alive for 44 months after diagnosis without recurrence
Case study: This disease demonstrates that Fubeikang has significant therapeutic effects on rare atypical FIP (manifested as localized transverse colon granuloma), with symptoms after treatment.
![]()
![]()
Send your inquiry directly to us